- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer prevention with rapamycin
Authors
Keywords
-
Journal
Oncotarget
Volume 14, Issue 1, Pages 342-350
Publisher
Impact Journals, LLC
Online
2023-04-14
DOI
10.18632/oncotarget.28410
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study
- (2022) Rabea Asleh et al. Journal of Clinical Medicine
- Cell senescence, rapamycin and hyperfunction theory of aging
- (2022) Mikhail V. Blagosklonny CELL CYCLE
- Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention
- (2022) Anne E. O'Shea et al. CLINICAL IMMUNOLOGY
- Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster
- (2022) Giuseppe Aiello et al. EMBO REPORTS
- Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice
- (2022) Mikhail V. Blagosklonny Aging-US
- Long‐term treatment of cancer‐prone germline PTEN mutant mice with low‐dose rapamycin extends lifespan and delays tumour development
- (2022) Priyanka Tibarewal et al. JOURNAL OF PATHOLOGY
- Rapamycin treatment during development extends life span and health span of male mice and Daphnia magna
- (2022) Anastasia V. Shindyapina et al. Science Advances
- Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer
- (2020) Marina P. Antoch et al. Oncotarget
- Rapamycin extends life span in Apc colon cancer FAP model
- (2020) Manish Parihar et al. Clinical Colorectal Cancer
- Rapamycin for longevity: opinion article
- (2019) Mikhail V. Blagosklonny Aging-US
- Deficient autophagy in epithelial stem cells drives aging in the freshwater cnidarian Hydra
- (2019) Szymon Tomczyk et al. DEVELOPMENT
- Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results
- (2018) Jacques Dantal et al. JOURNAL OF CLINICAL ONCOLOGY
- Does rapamycin slow down time?
- (2018) Mikhail V. Blagosklonny Oncotarget
- Aging promotes neoplastic disease through effects on the tissue microenvironment
- (2016) Fabio Marongiu et al. Aging-US
- mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model
- (2016) Juan Luis Callejas-Valera et al. CARCINOGENESIS
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
- (2016) James C Yao et al. LANCET
- Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients
- (2016) Gerhard Opelz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rapamycin in aging and disease: maximizing efficacy while minimizing side effects
- (2016) Simon C. Johnson et al. Oncotarget
- Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths
- (2016) Marjon A. Smit et al. Aging-US
- Reversing the aging stromal phenotype prevents carcinoma initiation
- (2016) Davina A. Lewis et al. Aging-US
- Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
- (2016) Elena A. Komarova et al. Aging-US
- New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis
- (2016) Maria Comas et al. Aging-US
- Rapamycin extends life span of Rb1+/− mice by inhibiting neuroendocrine tumors
- (2016) Carolina B. Livi et al. Aging-US
- MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
- (2015) Remi-Martin Laberge et al. NATURE CELL BIOLOGY
- Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice
- (2015) JAGAN M.R. PATLOLLA et al. ONCOLOGY REPORTS
- Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin
- (2014) Irina G Popovich et al. CANCER BIOLOGY & THERAPY
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- (2014) E. C. de Bruin et al. SCIENCE
- Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M
- (2014) Shigeru Kawabata et al. Cell Reports
- eRapa Restores a Normal Life Span in a FAP Mouse Model
- (2013) P. Hasty et al. Cancer Prevention Research
- Rapamycin extends murine lifespan but has limited effects on aging
- (2013) Frauke Neff et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapamycin slows aging in mice
- (2012) John E. Wilkinson et al. AGING CELL
- Caveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment
- (2012) Isabelle Mercier et al. AMERICAN JOURNAL OF PATHOLOGY
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
- (2012) Vladimir N. Anisimov et al. CELL CYCLE
- TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO
- (2012) Stacey Robida-Stubbs et al. Cell Metabolism
- Chemopreventive and Chemotherapeutic Actions of mTOR Inhibitor in Genetically Defined Head and Neck Squamous Cell Carcinoma Mouse Model
- (2012) Z.-J. Sun et al. CLINICAL CANCER RESEARCH
- Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009
- (2012) Pierluca Piselli et al. EUROPEAN JOURNAL OF CANCER
- Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
- (2012) Sylvie Euvrard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapamycin Is a Potent Inhibitor of Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate
- (2011) L. Allyson Checkley et al. Cancer Prevention Research
- Rapamycin decelerates cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
- (2010) Vladimir N. Anisimov et al. AMERICAN JOURNAL OF PATHOLOGY
- Prevention of cancer by inhibiting aging
- (2010) Mikhail V Blagosklonny CANCER BIOLOGY & THERAPY
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
- (2010) Richard A. Miller et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
- (2010) V. E. Kwitkowski et al. ONCOLOGIST
- Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels
- (2009) Wen Qiang Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting Mammalian Target of Rapamycin by Rapamycin Prevents Tumor Progression in an Oral-Specific Chemical Carcinogenesis Model
- (2009) R. Czerninski et al. Cancer Prevention Research
- Rapamycin for Chemoprevention of Upper Aerodigestive Tract Cancers
- (2009) P. A. Dennis Cancer Prevention Research
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
- (2009) David E. Harrison et al. NATURE
- Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APCMin/+ mice
- (2009) G E Koehl et al. ONCOGENE
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc 716 mice
- (2008) T. Fujishita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR−/− mice despite severe hypercholesterolemia
- (2007) Marc A. Mueller et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search